生物标志物 生物标志物
Jihwan Yun1, Daeun Shin2, Eun Hye Lee2
1Kyung Hee University Medical Center, Seoul, Korea, Republic of (South).
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
调整化化 (p-tau) 217切割值用于功能,BMI和贫血,可以改善阿尔茨海默病的检测. 量身定制值可以提高诊断准确度,特别是在功能受损的患者中.
科学领域:
- 神经学 神经学
- 生物标志物研究 生物标志物研究
- 阿尔茨海默氏症疾病的诊断方法
背景情况:
- 化化 (p-tau) 217是检测粉样β (Aβ) 阳性的有前途的生物标志物.
- 诸如功能障碍,体重指数和贫血等因素可以影响p-tau217水平.
- 最佳的p-tau217切断需要在不同的生理条件下进行调查.
研究的目的:
- 为了确定血p-tau217的最佳切割值如何随着估计的膜过率 (eGFR),体重指数 (BMI) 和贫血而变化.
- 评估这些因素对p-tau217对Aβ阳性的诊断准确性的影响.
主要方法:
- 一项针对2571名具有不同认知状态的参与者的多中心研究.
- 血p-tau217测量使用Alzpath Simoa免疫测试与Aβ PET成像一起测量.
- 参与者根据eGFR,BMI和贫血状况进行分类,以确定调整后的p-tau217截止值.
主要成果:
- 在患有功能障碍 (例如,eGFR <45),体重不足,肥胖和贫血的个体中观察到较高的最佳p-tau217截止值.
- 在严重功能障碍组 (eGFR <45) 应用标准切线将诊断准确度降低到48.3%.
- 调整的切断值提高了诊断性能,突出了个性化值的必要性.
结论:
- 根据功能,BMI和贫血来定制血p-tau217切断值对于准确的阿尔茨海默病诊断至关重要.
- p-tau217的诊断效用受到这些生理参数的显著影响.
- 对于患有功能损害 (eGFR <45) 的患者群体,具体的调整至关重要.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


